Dextromethorphan and guaifenesin use should be monitored diligently in people with "bad metabolizer" CYP2D6 enzyme amounts and patients who will be sedated. This mixture medication has a large median harmful dose (TD50) to median effective dose (ED50) ratio (or therapeutic index) in these people. When combined with other antidepressants, recent https://hire-a-hacker-to-recover34333.webdesign96.com/30661093/getting-my-dextromethorphan-dxm-for-sale-to-work